Abstract
Although there are clinical data suggesting a direct relationship between neonatal nephrotic syndrome and placental transfer of proinflammatory cytokines from mothers with HELLP syndrome, there is no direct evidence that these inflammatory cytokines are pathogenic. Here, the first human model of placental transfer of proinflammatory cytokines from a mother with HELLP syndrome to a newborn, resulting in neonatal nephrotic syndrome is described. Forty-eight hours after delivery, the neonate developed nephrotic syndrome and abnormalities in renal function which resolved completely during the 5 days following the initiation of therapy with hydrocortisone, albumin, and furosemide. The newborn’s cord blood showed increased concentrations of interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha that were identical to those found in the mother’s serum. Hydrocortisone therapy was discontinued after a 2-week course. Clinical and laboratory improvements were associated with a marked decline in serum cytokine levels, indicating that the proinflammatory cytokines were pathogenic. The neonate remained in remission with no recurrence of nephrotic syndrome during 12 months of follow-up. These findings demonstrate that the placental transmission of circulating cytokines causing HELLP syndrome occurred during pregnancy and may have resulted in nephrotic syndrome in the neonate.
References
Niaudet P (2004) Genetic forms of nephritic syndrome. Pediatr Nephrol 19:1313–1318
Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft für Pädiatrische Nephrologie Study Group (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 19:907–919
Habib R (1993) Nephrotic syndrome in the first year of life. Pediatr Nephrol 7:347–353
Stone JH (1998) HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 280:559–562
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169:1000–1006
Wang X, Athayde N, Trudinger B (2003) A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Gynecol 189:1445–1451
Aaltonen A, Heikkinene T, Hakala K, Laine K, Alanen A (2005) Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 106:802–807
Zaretsky MV, Alexander JM, Byrd W, Bawdon RE (2004) Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103:545–550
Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A (2007) Uteroplacental ischemic results in proteinuric hypertension and elevated sFLT-1. Kidney Int 71:977–984
Rusterholz C, Hahn S, Holzgreve W (2007) Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclamsia. Semin Immunopathol 29:151–162
Lagrue G, Branellec A, Niaudet P, Heslan JM, Guillot F, Lang P (1991) Transmission of nephrotic syndrome to two neonates. Spontaneous regression. Presse Méd 16:255–257
Gunnes T, Akcakus M, Dusunsel R, Cetin N, Poyrazoglu H (2002) Transient proteinuria in an infant born to a mother with HELLP syndrome. Eur J Pediatr 161:614–615
Dötsch J, Hohmann M, Kuhl PG (1997) Neonatal morbidity and mortality associated with maternal hemolysis elevated liver enzymes and low platelets syndrome. Eur J Pediatr 156:389–391
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Assadi, F. Neonatal nephrotic syndrome associated with placental transmission of proinflammatory cytokines. Pediatr Nephrol 26, 469–471 (2011). https://doi.org/10.1007/s00467-010-1700-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-010-1700-1